Inside Novartis' outsized play in India Inside Forbes India
-
- Business
Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis, the youngest amongst his pharma peers at 47, a trained doctor who has come up the ranks from R&D. Balachandran delves into our latest cover story which dissects Novartis' play in India
Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis, the youngest amongst his pharma peers at 47, a trained doctor who has come up the ranks from R&D. Balachandran delves into our latest cover story which dissects Novartis' play in India
12 min